




Date: 21st July 2026
Healthcare products face a different level of risk online. From unauthorized sellers and parallel imports to regulatory complexity and patient safety concerns, online distribution has evolved far beyond counterfeit detection alone.
Join Corsearch experts Maria Knights and Paolo Emilio Ascoli as they explore how healthcare brands can move beyond reactive enforcement and take control of increasingly complex online distribution ecosystems.
What You’ll Learn
- How online healthcare marketplaces are changing across Prescription and OTC medicines
- The growth of unauthorized sellers, product diversion, and parallel imports across and beyond the EEA
- How language, labelling, storage conditions, and regulatory approvals create additional risk exposure
- What changing EU pharmaceutical regulation means for healthcare brands in 2026
- How Digital Services Act (DSA) obligations intersect with healthcare enforcement strategies
Who Should Attend?
Healthcare & Pharmaceutical Brands • Brand Protection • Legal & IP • Regulatory Affairs • Ecommerce & Marketplace Teams • Distribution & Supply Chain Leaders
See how PharmaCheck™ accelerates name qualification
From early-stage screening to post-clearance checks, we help you move faster with confidence — while avoiding missteps new, and help you move forward — faster.






.avif)



.png)
.png)



.avif)





